Bank Julius Baer & Co. Ltd, Zurich Incyte Corp Transaction History
Bank Julius Baer & Co. Ltd, Zurich
- $23.9 Billion
- Q2 2024
A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Incyte Corp stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 1,348 shares of INCY stock, worth $88,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,348
Previous 1,500
10.13%
Holding current value
$88,738
Previous $85,000
4.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding INCY
# of Institutions
629Shares Held
198MCall Options Held
766KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.02 Billion24.77% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.41 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.34 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.01 Billion0.58% of portfolio
-
State Street Corp Boston, MA10.9MShares$714 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.6B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...